×
Novel Antipsychotic Use in Schizophrenia PDF
$ 40.00
Novel Antipsychotic Use in Schizophrenia PDF quantity
$ 40.00
×
The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF
$ 40.00
The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF quantity
$ 40.00
×
Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study PDF
$ 40.00
Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study PDF quantity
$ 40.00
×
Reflections on Perinatal Depression Treatment PDF
$ 40.00
Reflections on Perinatal Depression Treatment PDF quantity
$ 40.00
×
Delusional Infestation With Black Mold Presenting to the General Hospital PDF
$ 40.00
Delusional Infestation With Black Mold Presenting to the General Hospital PDF quantity
$ 40.00
×
Effect of Reboxetine on Depression in Parkinson's Disease Patients PDF
$ 40.00
Effect of Reboxetine on Depression in Parkinson's Disease Patients PDF quantity
$ 40.00
×
Sublingual Ketamine for Rapid Relief of Suicidal Ideation PDF
$ 40.00
Sublingual Ketamine for Rapid Relief of Suicidal Ideation PDF quantity
$ 40.00
×
The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals PDF
$ 40.00
The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals PDF quantity
$ 40.00
×
Neurocognitive Effects of Neurofeedback in Adolescents With ADHD: A Randomized Controlled Trial PDF
$ 40.00
Neurocognitive Effects of Neurofeedback in Adolescents With ADHD: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Clomipramine Treatment of Panic Disorder: Pros and Cons PDF
$ 40.00
Clomipramine Treatment of Panic Disorder: Pros and Cons PDF quantity
$ 40.00
×
A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors PDF
$ 40.00
A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors PDF quantity
$ 40.00
×
Mitigation of Anxiety, Agitation, and Pain in Critically Ill Patients PDF
$ 40.00
Mitigation of Anxiety, Agitation, and Pain in Critically Ill Patients PDF quantity
$ 40.00
×
Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF
$ 40.00
Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF quantity
$ 40.00
×
Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain PDF
$ 40.00
Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain PDF quantity
$ 40.00
×
Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder: A Meta-Analysis PDF
$ 40.00
Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder: A Meta-Analysis PDF quantity
$ 40.00
×
Buspirone for Comorbid Anxiety in Autism PDF
$ 40.00
Buspirone for Comorbid Anxiety in Autism PDF quantity
$ 40.00
×
The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases PDF
$ 40.00
The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases PDF quantity
$ 40.00
×
Camptocormia and Antipsychotic Medications PDF
$ 40.00
Camptocormia and Antipsychotic Medications PDF quantity
$ 40.00
×
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia PDF
$ 40.00
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia PDF quantity
$ 40.00
×
The Course of Eating Disorders During COVID-19 PDF
$ 40.00
The Course of Eating Disorders During COVID-19 PDF quantity
$ 40.00
×
Trajectories of Perinatal Depressive and Anxiety Symptoms in a Community Cohort PDF
$ 40.00
Trajectories of Perinatal Depressive and Anxiety Symptoms in a Community Cohort PDF quantity
$ 40.00
×
Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records PDF
$ 40.00
Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records PDF quantity
$ 40.00
×
Neuropsychiatric Manifestations of Mpox (monkeypox) Virus Amidst a Global Outbreak PDF
$ 40.00
Neuropsychiatric Manifestations of Mpox (monkeypox) Virus Amidst a Global Outbreak PDF quantity
$ 40.00
×
A Systematic Review of Fear Learning, Extinction Learning, and Reversal Learning in Obsessive-Compulsive Disorder: Implications for Treatment PDF
$ 40.00
A Systematic Review of Fear Learning, Extinction Learning, and Reversal Learning in Obsessive-Compulsive Disorder: Implications for Treatment PDF quantity
$ 40.00
×
“It Is Hard to Be a Woman With Schizophrenia”: Randomized Controlled Trial of a Brief Video Intervention to Reduce Public Stigma in Young Adults PDF
$ 40.00
“It Is Hard to Be a Woman With Schizophrenia”: Randomized Controlled Trial of a Brief Video Intervention to Reduce Public Stigma in Young Adults PDF quantity
$ 40.00
×
A Computer Algorithm for Calculating the Adequacy of Antidepressant Treatment in Unipolar and Bipolar Depression PDF
$ 40.00
A Computer Algorithm for Calculating the Adequacy of Antidepressant Treatment in Unipolar and Bipolar Depression PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart